Association between village coverage of 13-valent pneumococcal conjugate vaccine and vaccine-type pneumococcal carriage among children aged 0–59 months with pneumonia in Papua New Guinea: an observational study

Background: Pneumococcal conjugate vaccine (PCV) prevents pneumococcal disease and pneumonia, but indirect effects are poorly understood in low-coverage, high-burden settings like Papua New Guinea (PNG). PNG introduced 13-valent PCV (PCV13) in 2014. We aimed to assess direct and indirect effectivene...

Descrición completa

Detalles Bibliográficos

Principais autores:	Rebecca L. Ford, Eleanor F.G. Neal, Joycelyn Sapura, John Kave, Birunu Nivio, Mary Dreyam, John Samatoe, Wendy Kirarock, Jocelyn Chan, Jason Hinds, Monica L. Nation, Casey L. Pell, Belinda D. Ortika, Ahmed Alamrousi, Cattram D. Nguyen, Eileen M. Dunne, Catherine Satzke, William S. Pomat, Christopher C. Blyth, Fiona M. Russell
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2026-06-01
Series:	Vaccine: X
Assuntos:	Pneumococcal conjugate vaccine PCV13 Vaccine-type carriage Indirect effects Coverage Papua New Guinea
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2590136226000343
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!